Credit Suisse: Upgraded Clover Bio-B (02197) rating to “outperform the market” and raised the target price to HK$3.4
Zhitong FinanceFeb 22, 2023 11:20
Hong Kong stocks change | Shamrock-B (02197) falls by nearly 10% Credit Suisse says reduced demand for Gavi vaccine downgraded the company's rating to "neutral"
Zhitong FinanceNov 25, 2022 14:25
IPO News: Clover Biopharmaceuticals Co., Ltd. - B (2197.HK)
致富證券Oct 25, 2021 00:00
No Data
No Data